[ Price : $8.95]
Federal Register Notice: FDA determines that Travatan 0.004% was not withdrawn from sale for reasons of safety or effectiveness.[ Price : $8.95]
Sens. Bingaman and Vitter introduce legislation to expand generic drug marketing exclusivity to companies other than first filers.[ Price : $8.95]
Consulting editor John Scharmann takes a critical look at FDAs 50-year-long hesitation to curb the growth-promotant, subtherapeuti...[ Price : $8.95]
Two congressmen ask the Government Accountability Office to research and report on dietary supplement adverse event reporting.[ Price : $8.95]
At a Senate hearing, CDRH director Jeff Shuren provides his perspective on how to reduce rising medical device approval times.[ Price : $8.95]
CooperVision says it is now recalling some lots of its Avaira Sphere contact lenses.[ Price : $8.95]
FDA warns Taiwans Vega Technologies about Quality System violations in its manufacturing of nebulizers and thermometers.[ Price : $8.95]
FDA asks Mallinckrodt to stop distributing 15 mL sample bottles of Pennsaid due to reports of improper administration by patients.